Applied DNA Awarded Additional U.S. Patent on its fiberTyping® Cotton Genotyping Technology
February 22 2018 - 5:30AM
Business Wire
New Patent Strengthens the Company’s Robust
Cotton Genotyping and Traceability Patent Portfolio
Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the
"Company"), is pleased to announce the receipt of a Notice of
Allowance for its U.S. Patent Application No. 14/191,947 (US
2014/0295423 A1) entitled Methods for Genetic Analysis of Textiles
Made of Gossypium barbadense and Gossypium hirsutum Cotton. The
allowed patent application, which will issue as a U.S. patent in
the next few months, significantly bolsters the Company’s patent
protection for its fiberTyping technology.
The newly allowed ‘947 application protects the Company’s
proprietary methods of cotton species identification in a
manufactured article via the extraction and analysis of target
sequences found in the chloroplast DNA of the article. The allowed
claims cover chloroplast DNA target sequence analysis via all known
sequence-specific DNA analysis techniques, including qPCR
(quantitative polymerase chain reaction) and hybridization probe
technologies.
With the addition of the allowed ‘947 application, the Company
has been granted 4 U.S. patents on its fiberTyping technology,
which now cover the identification of a cotton species in a
manufactured article via both target sequence and length
polymorphism analysis of chloroplast DNA. The Company plans to
closely monitor cotton products imported into the U.S. that allege
to be verified via mature cotton fiber genotyping analysis, and
will act accordingly.
Dr. James Hayward, president and CEO of Applied DNA, noted,
“With the allowance of this patent application, we have now
successfully protected both means by which the chloroplast DNA of
cotton fibers can be analyzed, giving us a strong patent position
in the cotton genotyping market.” Dr. Hayward continued, “Our
fiberTyping technology, coupled with our patented SigNature® T
molecular tags, are the ultimate combination for the corroboration
of cotton content label claims. No other system can provide the
immutable forensic level identity and traceability proof our
technology provides. With the recent announcement of our GeoTyping™
technology, we are continuing to push the boundaries of cotton
genotyping science.”
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
CertainT® platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is
at the heart of a family of uncopyable, security and authentication
solutions such as SigNature®T and fiberTyping®, targeted towards
textiles and apparel, BackTrac®, DNAnet® and SmartDNA® for
anti-theft and loss prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can
be used to prosecute perpetrators. Applied DNA Sciences is also
engaged in the large-scale production of specific DNA sequences
using the polymerase chain reaction.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to our lack of significant revenues, limited
financial resources, limited market acceptance, history of net
losses, market competition and various other factors detailed from
time to time in Applied DNA’s SEC reports and filings, including
our Annual Report on Form 10-K filed on December 28, 2017 and our
subsequent quarterly report on Form 10-Q filed on February 8, 2018,
which are available at www.sec.gov. Applied DNA undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date
hereof to reflect the occurrence of unanticipated events,
unless otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180222005423/en/
For Applied DNA Sciences, Inc.Investors:Sanjay M.
Hurry, 212-838-3777shurry@lhai.comorMedia:Angie Mathews,
781-639-4924angie@cgprpublicrelations.comorLegal:Clay
Shorrock, 631-240-8814General
Counselclay.shorrock@adnas.comorADNAS:MeiLin Wan,
631-240-8849meilin.wan@adnas.comorweb: www.adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024